Specialist care for Urological Cancers · LucknowTeleconsultation available for patients across India
Meet the Doctor Blogs WhatsApp Us +91-9559776664
Home›Treatments›Bladder Cancer

Bladder Cancer at a Glance

Blood is the key sign

Painless, intermittent blood in the urine should always be investigated.

Smoking matters most

Tobacco is the single biggest risk factor, including beedi and chewed tobacco.

Usually caught early

About three in four tumours have not invaded the bladder muscle at diagnosis.

Follow-up is essential

Bladder tumours can recur, so regular cystoscopy is part of care.

Warning Signs and Risk Factors

  • Visible blood in the urine, which may come and go
  • Red blood cells found on a routine urine test
  • Frequency, urgency or burning without an infection

Besides smoking, long-term exposure to dyes, rubber, leather, paint and industrial chemicals increases the risk, as do previous pelvic radiation and some chemotherapy drugs. If blood was found only on a urine test, the microhematuria checker below shows what level of evaluation is usually advised.

How Bladder Cancer Is Diagnosed

Cystoscopy

A thin flexible telescope is passed into the bladder under local anaesthetic gel. It takes a few minutes and is the most reliable way to see a bladder tumour; scans can miss small or flat lesions.

CT urography and urine cytology

A contrast CT checks the kidneys and ureters for tumours and stones, and urine cytology looks for cancer cells, particularly from high-grade disease.

TURBT

Transurethral resection removes the tumour through the urethra and provides tissue for diagnosis. A good-quality resection includes bladder muscle so that the depth of invasion can be judged. Some high-risk tumours need a second resection a few weeks later.

Stage and Grade

StageMeaningUsual approach
TaConfined to the inner liningTURBT, with a chemotherapy instillation; BCG if high grade
CISFlat, high-grade change in the liningBCG instillations
T1Into the layer beneath the liningRepeat TURBT and BCG; early cystectomy in selected high-risk cases
T2Into the bladder muscleChemotherapy, then radical cystectomy, or trimodality therapy
T3–T4Beyond the bladder wallMultimodal treatment planned with oncology

Grade describes how abnormal the cells look. Low-grade tumours tend to recur but rarely invade; high-grade tumours carry a greater risk of progression and need more intensive treatment. The EORTC risk tables combine these features into an estimate of recurrence and progression.

Treatment Options

Non-muscle-invasive disease

After TURBT, low-risk tumours are usually treated with a single dose of chemotherapy into the bladder. Intermediate-risk tumours may need a course of instillations. High-risk tumours are treated with BCG, given weekly for six weeks and then as maintenance for one to three years.

Muscle-invasive disease

The standard treatment is chemotherapy followed by robotic radical cystectomy, removing the bladder and pelvic lymph nodes. In carefully selected patients, trimodality therapy (a thorough TURBT followed by chemotherapy and radiation) can preserve the bladder.

When BCG does not work

If high-risk disease returns despite adequate BCG, radical cystectomy is usually recommended. Newer bladder-sparing drugs may be considered for patients who are not fit for surgery.

Life After Cystectomy: Urinary Diversion

Ileal conduit

A short segment of bowel carries urine to a small opening (stoma) on the abdomen, where it drains into a discreet bag. It is the simplest and most widely used option.

Neobladder

A new reservoir made from bowel is joined to the urethra, so urine is passed through the normal route. It needs good kidney function and commitment to bladder training.

Recovery and Follow-Up

After TURBT, mild burning and some blood in the urine for a few days are common. During BCG, flu-like symptoms for a day or two after each dose are expected. Surveillance cystoscopy is repeated at regular intervals, most often in the first two years, and the upper urinary tract is imaged periodically.

After cystectomy, recovery takes several weeks. Follow-up includes scans, kidney function, vitamin B12 levels and support with the stoma or neobladder.

Frequently Asked Questions

The bleeding stopped on its own. Do I still need tests?

Yes. Bleeding from bladder tumours often stops and returns. If the bleeding has stopped, that does not mean the cause has gone.

Is cystoscopy painful?

Flexible cystoscopy is done with local anaesthetic gel and usually takes a few minutes. Most people describe mild discomfort rather than pain.

What is BCG and how does it work?

BCG is a weakened bacterium placed into the bladder through a catheter. It triggers an immune response that lowers the risk of high-risk tumours returning or progressing.

Will I need my bladder removed?

Most people with Bladder Cancer do not. Removal is advised for muscle-invasive disease and for some high-risk tumours that do not respond to BCG.

Can I live a normal life with a urostomy bag?

Yes. Most people return to work, travel and normal activities. Modern appliances are discreet, and stoma nurses help with the adjustment.

Is complete Bladder Cancer treatment available in Lucknow?

Yes. Cystoscopy, TURBT, BCG, robotic radical cystectomy and long-term surveillance are all available with Dr. Anshuman Singh in Lucknow.

Patient Tools

Understand Your Reports

Whether a routine urine test has shown blood, or you are planning treatment after TURBT, these guideline-based tools help you prepare for the discussion.

Results are estimates for groups of patients and do not replace medical advice. Entries stay in your browser and are not stored or sent.

Patient tool

Microscopic blood in urine: what evaluation is needed?

If a routine urine test found red blood cells but you have not seen blood yourself, this checker uses the American Urological Association criteria to suggest the appropriate level of evaluation. If you have seen blood in your urine, please consult a urologist directly; this tool does not apply.

Sex
Smoking history
Red blood cells per high-power field (RBC/HPF) on urine microscopy
Have you ever seen blood in your urine?
Other risk factors (tick any)

Fill in age, sex, RBC count and history of visible blood.

About this tool

Barocas DA et al., AUA/SUFU Guideline on Microhematuria, J Urol 2020. Pack-years = (cigarettes per day ÷ 20) × years smoked. The highest category met by any single factor determines your risk group.

Patient tool

Recurrence and progression risk (EORTC)

After TURBT for early (Ta/T1) Bladder Cancer, details from the pathology report can estimate the chance of the cancer returning, or of it growing into the bladder muscle. Many patients find this helpful when discussing BCG treatment and the cystoscopy schedule.

Number of tumours
Size of largest tumour
Prior recurrence rate
T category
Concurrent carcinoma in situ (CIS)
Grade (WHO 1973)

Answer all six items from your TURBT report.

About this tool

Sylvester RJ et al., Eur Urol 2006. Based mainly on patients treated without BCG maintenance. Risks are lower with adequate BCG therapy, and the EAU 2021 NMIBC scoring model is also used to choose treatment. Many reports now use low/high grade (WHO 2004/2016); ask your doctor for the WHO 1973 grade if it is not stated.

Patient Experiences

Shared by patients and families treated by Dr. Anshuman Singh.

“

I was diagnosed with a tumor in my urinary bladder, and my treatment was done at Medanta Hospital, Gurgaon, under the care of Uro-Oncology specialists Dr. Gagan Gautam and Dr. Anshuman Singh. Today, I am completely tumor-free.

AK
Abhay Kumar DubeyPatient
“

He is highly qualified doctor, he is best in uro- oncology. I have personal experience about him during my father treatment for Urine bladder cancer at medanta hospital. And my father is fine now.

SM
Shiksha MishraFamily Member

Seen blood in your urine?

Even a single episode deserves evaluation. Book a consultation, or share your reports for review by teleconsultation.

WhatsApp +91-9559776664